Denlab - Company finances
|
EUR
|
2021
From: 2021-05-31
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 5,835 | 14,262 | 20,689 | 26,488 | 25,012 |
| Profit before tax | - | - | -247 | 3,158 | 401 |
| Net profit | 2,120 | 6,926 | -356 | 2,725 | 3 |
| Equity | 3,120 | 10,046 | 9,690 | 12,416 | 5,564 |
| Liabilities | 4,000 | 757 | 1,530 | 2,075 | 992 |
| Non-current assets | 2,011 | 1,580 | 3,796 | 2,472 | 2,614 |
| Current assets | 5,109 | 9,223 | 7,424 | 12,019 | 3,942 |
| Total assets | 7,120 | 10,803 | 11,220 | 14,491 | 6,556 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 367 | 109 | 433 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +144.4% | +45.1% | +28.0% | -5.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 29.8% | 64.1% | -3.2% | 18.8% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 67.9% | 68.9% | -3.7% | 21.9% | 0.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 36.3% | 48.6% | -1.7% | 10.3% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | -1.2% | 11.9% | 1.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.3 | 0.1 | 0.2 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Denlab - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-27 | 2026-07-31 | 94.72 |
| 2026-06-02 | 2026-06-26 | 272.20 |
| 2026-05-03 | 2026-06-01 | 134.94 |
| 2024-10-01 | 2024-10-31 | 219.08 |
| 2024-05-03 | 2024-05-31 | 1081.05 |
| 2024-05-02 | 2024-05-02 | 323.70 |
| 2024-04-26 | 2024-05-01 | 9.60 |
| 2024-04-09 | 2024-04-25 | 467.74 |
| 2024-03-08 | 2024-04-08 | 27.72 |
| 2022-07-01 | 2022-07-31 | 50.95 |
| 2021-08-13 | 2021-09-30 | 44.81 |
Denlab - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Denlab, MB (code 305781812) is a Small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €25.0K, slightly below the €26.5K reported in 2024, but still above the €20.7K achieved in 2023. Over the full two-year period, revenue increased by 20.9%, although the latest year shows a modest 5.6% decline year on year. Profitability weakened sharply in 2025: net profit was only €3 after a net profit of €2.7K in 2024 and a net loss of €356 in 2023. As a result, the 2025 margin was near zero. At year-end 2025, total assets stood at €6.6K, equity at €5.6K and liabilities at €992, indicating a very strong equity position. The equity ratio was 84.9% and debt-to-equity 0.18, while asset turnover remained high at 3.82x. Return on equity and return on assets were both minimal in 2025, reflecting the very small profit base.